LLY vs RVTY
By Alex · Tickerpine
Eli Lilly and Company vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | RVTY |
|---|---|---|
| Price | $1,443.50 | $154.39 |
| Market cap | $1.29T | $17.24B |
| P/E ratio | 46.9 | 68.6 |
| ROE | 86.02% | 3.45% |
| Profit margin | 31.90% | 8.61% |
| Revenue growth | 38.60% | 4.30% |
| Dividend yield | 0.48% | 0.18% |
| Beta | 0.39 | 1.09 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs RVTY in plain English
- LLY is the bigger company — about 74.6× the market cap of RVTY.
- LLY is cheaper on earnings (P/E 46.9 vs 68.6).
- LLY earns a higher return on equity (86% vs 3%).
- LLY is growing revenue faster (39% vs 4%).
- LLY has the higher dividend yield (0.48% vs 0.18%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.